跳至主要内容
临床试验/NCT04815304
NCT04815304已完成不适用

Clinical Features of Severe Acute Respiratory Syndrome Coronavirus 2 Patients Admitted to the Intensive Care Units of Academic Hospital of L'Aquila (Italy)

San Salvatore Hospital of L'Aquila1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年3月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
Peripheral lymphocyte subsets

研究概览

简要总结

The data were retrospectively collected during the first and the second wave of epidemic in COVID-19 patients with Severe Acute Respiratory Syndrome Coronavirus 2, at the moment of intensive care unit admission and during the in intensive care unit staying.

详细描述

At the moment of intensive care unit admission and during the in intensive care unit staying, the following data were collected: peripheral lymphocyte subsets were measured by multiple-color flow cytometry, chest computed tomography and ultrasonography scans, arterial blood gas parameters (pH, partial pressure of carbon dioxide, partial pressure of oxygen, concentration of hydrogen carbonate, base excess, and arterial oxygen saturation), and pain assessed by using numeric rating scale.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • COVID-19 patients
  • Acute respiratory distress syndrome
  • needing of ventilatory support

排除标准

  • asymptomatic COVID-19 patients
  • few symptoms
  • mild symptoms
  • without needing of ventilatory support

结局指标

主要结局

Peripheral lymphocyte subsets

时间窗: Change from date of hospitalization until the date of hospital discharge or date of death from any cause, whichever came first, assessed at 60 weeks

Peripheral lymphocyte subsets were measured by multiple-color flow cytometry,

次要结局

  • Upper airway damages(From date of hospitalization until the date of hospital discharge or date of death from any cause, whichever came first, assessed every day up to 60 weeks)
  • Chest computed tomography(From date of hospitalization until the date of hospital discharge or date of death from any cause, whichever came first, assessed every 10 days up to 60 weeks)
  • Pain assessment(From date of hospitalization until the date of hospital discharge or date of death from any cause, whichever came first, assessed every day up to 60 weeks)
  • Chest ultrasonography(From date of hospitalization until the date of hospital discharge or date of death from any cause, whichever came first, assessed every day up to 60 weeks)

研究者

发起方
San Salvatore Hospital of L'Aquila
申办方类型
Other
责任方
Principal Investigator
主要研究者

Emiliano Petrucci

Medical Doctor

San Salvatore Hospital of L'Aquila

研究点 (1)

Loading locations...

相似试验